About EyeSense
EyeSense is a company based in Stockstadt Am Main (Germany) founded in 2006. It operates as a HealthTech and Product-as-a-Service. EyeSense has raised $8.23 million across 3 funding rounds from investors including Qiagen, Life Sciences Partners and Lee’s PHARM. The company has 15 employees as of December 31, 2020. EyeSense offers products and services including FiberSense Sensor and EyeSense App. EyeSense operates in a competitive market with competitors including Dexcom, Livongo, One Drop, mySugr and Laborie Medical, among others.
- Headquarter Stockstadt Am Main, Germany
- Employees 15 as on 31 Dec, 2020
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Eyesense Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.23 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Qiagen
& 5 more
-
Employee Count
15
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EyeSense
EyeSense offers a comprehensive portfolio of products and services, including FiberSense Sensor and EyeSense App.
Continuous glucose monitoring is enabled by optical sensor.
Real-time glucose data is provided to users' smartphones.
Funding Insights of EyeSense
EyeSense has successfully raised a total of $8.23M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EyeSense
EyeSense has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Qiagen, Life Sciences Partners and Lee’s PHARM.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment firm
|
Locked | Locked | Locked | |
|
Private equity investments in life sciences businesses are managed.
|
Locked | Locked | Locked | |
|
Early to mid stage life sciences-focused VC firm investing in geographies such as Europe
|
Locked | Locked | Locked |
Investor details for EyeSense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EyeSense
Investment portfolio details for EyeSense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EyeSense
Detailed financials for EyeSense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eyesense Comparisons
Peer comparison for EyeSense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EyeSense
EyeSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, One Drop, mySugr and Laborie Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| Locked | Locked | Locked |
Provider of smart devices for diabetes management for patients and doctors
|
|
| Locked | Locked | Locked |
Provider of workforce healthcare solutions
|
|
| Locked | Locked | Locked |
Gamified apps for diabetes management and therapy are provided.
|
|
| Locked | Locked | Locked |
Medical products for female lower urinary tract dysfunctions are provided.
|
|
| Locked | Locked | Locked |
Implantable continuous glucose monitoring systems are provided for diabetes management.
|
Detailed competitors of EyeSense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eyesense
Complete news archive for EyeSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EyeSense
EyeSense was founded in 2006.
EyeSense is headquartered in Stockstadt Am Main, Germany. It is registered at Stockstadt Am Main, Bavaria, Germany.
EyeSense is a funded company, having raised a total of $8.23M across 3 funding rounds to date.
As of Dec 31, 2020, the latest employee count at EyeSense is 15.
Advanced medical technology for diabetes management is provided by EyeSense. Focus is placed on continuous glucose monitoring through innovative optical sensors. The FiberSense platform is designed for precision and sustainability, targeting Type-1 and Type-2 diabetes patients. Additional biometric data monitoring, such as ketones and cortisol, is planned for future expansion. The healthcare sector is served with solutions emphasizing reliability, discretion, and environmental responsibility. User-friendly systems with real-time alerts are integrated for seamless health management. Software updates are intended to ensure adaptability to evolving user needs.
EyeSense's top competitors include Dexcom, Senseonics and One Drop.
EyeSense offers FiberSense Sensor and EyeSense App.
EyeSense has 6 investors. Key investors include Qiagen, Life Sciences Partners, Lee’s PHARM, Rosetta Capital, and BioMedPartners.